Insmed, Inc. (INSM)
109.14
-6.48
(-5.60%)
USD |
NASDAQ |
May 15, 16:00
109.44
+0.30
(+0.27%)
After-Hours: 20:00
Insmed Profit Margin (Quarterly) : -53.46% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -30.32% |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| PTC Therapeutics, Inc. | -1.03% |
| Revolution Medicines, Inc. | -- |
| United Therapeutics Corp. | 35.18% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -158.3% |
| Return on Assets | -53.89% |
| Return on Invested Capital | -73.61% |
| Gross Profit Margin (Quarterly) | 83.82% |
| Operating Margin (Quarterly) | -65.46% |
| Return on Net Operating Assets | -213.3% |